Dhanuka Agritech Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.7 pts more than Nifty Microcap 250 and 11.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with a clean (unmodified) opinion from statutory auditors S S Kothari Mehta & Co LLP. Revenue from operations grew about 15.7% YoY to Rs. 2,03,515 lacs, while consolidated profit after tax rose roughly 24% to Rs. 29,696 lacs, reflecting margin expansion. The Board recommended a final dividend of Rs. 2 per share (100% on Rs. 2 face value), with record date July 18, 2025, to be paid within 30 days of the 40th AGM on August 1, 2025. During the year, the company completed a Rs. 100 crore buyback (5 lakh shares at Rs. 2,000 each) and acquired international rights for active ingredients Iprovalicarb and Triadimenol from Bayer AG, targeting expansion into 20+ countries. Independent Director Mr. Siraz Azmat Chaudhary will cease to be a director after completing his first term on July 22, 2025.
A solid topline and stronger profit growth signal healthy demand and improving margins for this agro-chemical player. The clean audit, 100% dividend, completed buyback, and international expansion push are shareholder-friendly and likely to be viewed positively by the market.